Search results
Results from the WOW.Com Content Network
Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.
The business scope expanded significantly when it acquired the rival biotechnology and cell culture company Life Technologies in 2000; Life had been formed in 1983 when GIBCO (Grand Island Biological Company) which had been founded around 1960 in New York, merged with a reagent company called Bethesda Research Laboratories. The company ...
The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. [30] In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs manufactures, and delivers technologies used in bioprocessing. [31]
Applied Biosystems is one of various brands under the Life Technologies brand of Thermo Fisher Scientific corporation. The brand is focused on integrated systems for genetic analysis, which include computerized machines and the consumables used within them (such as reagents).
In 2008, Applied Biosystems merged with Invitrogen to form Life Technologies. [4] In 2009, Danaher Corporation paid approximately $1.1 billion [5] to buy SCIEX from MDS and the Applied Biosystems/MDS SCIEX joint venture business from Life Technologies. The business unit now operates as SCIEX within the Life Sciences Division of Danaher and is ...
Life Technologies, had been formed by the merger of GIBCO and Bethesda Research Laboratories in 1983. Clinical uptake of ViraPap was slow, and Life sold the test and associated intellectual property to Digene in 1990, soon after Digene was acquired by the Whitehead group. Digene's history in non-radioactive detection methods allowed it to ...
SOLiD (Sequencing by Oligonucleotide Ligation and Detection) is a next-generation DNA sequencing technology developed by Life Technologies and has been commercially available since 2006. This next generation technology generates 10 8 - 10 9 small sequence reads at one time.
Sigma Life Science provides products such as custom DNA/RNA oligos; custom DNA and LNA probes; siRNA; isotopically-labelled peptides and peptide libraries. Sigma Advanced Genetic Engineering (SAGE) Labs is a division within Sigma-Aldrich that specializes in genetic manipulation of in vivo systems for special research and development applications.